Credit Suisse Ag Supernus Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 54,671 shares of SUPN stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,671

Previous 54,644 0.05%

Holding current value

$1.98 Million

Previous $1.58 Million 17.9%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.11 - $35.17 $731 - $949	27 Added 0.05%	54,671 $1.86 Million
Q4 2023 Feb 08, 2024	BUY	$22.72 - $29.68 $89,789 - $117,295	3,952 Added 7.8%	54,644 $1.58 Million
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $80,118 - $95,636	-2,906 Reduced 5.42%	50,692 $1.4 Million
Q2 2023 Aug 11, 2023	BUY	$29.91 - $38.73 $221,663 - $287,028	7,411 Added 16.05%	53,598 $1.61 Million
Q1 2023 May 10, 2023	BUY	$34.93 - $42.03 $12,644 - $15,214	362 Added 0.79%	46,187 $1.67 Million
Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $16,166 - $19,697	520 Added 1.15%	45,825 $1.63 Million
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $7,226 - $8,887	251 Added 0.56%	45,305 $1.53 Million
Q2 2022 Aug 12, 2022	SELL	$25.33 - $34.25 $256,846 - $347,295	-10,140 Reduced 18.37%	45,054 $1.3 Million
Q1 2022 May 16, 2022	BUY	$28.51 - $32.9 $74,411 - $85,869	2,610 Added 4.96%	55,194 $1.78 Million
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $16,982 - $22,037	644 Added 1.24%	52,584 $1.53 Million
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $131,376 - $175,187	-5,581 Reduced 9.7%	51,940 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$26.72 - $33.19 $110,914 - $137,771	4,151 Added 7.78%	57,521 $1.77 Million
Q1 2021 May 14, 2021	SELL	$24.15 - $31.45 $2.4 Million - $3.12 Million	-99,224 Reduced 65.02%	53,370 $1.4 Million
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $343,273 - $500,559	-19,394 Reduced 11.28%	152,594 $3.84 Million
Q3 2020 Nov 13, 2020	SELL	$20.2 - $25.05 $302,676 - $375,349	-14,984 Reduced 8.01%	171,988 $3.59 Million
Q2 2020 Aug 12, 2020	BUY	$17.09 - $24.89 $328,076 - $477,813	19,197 Added 11.44%	186,972 $4.44 Million
Q1 2020 May 13, 2020	BUY	$14.45 - $24.69 $1.52 Million - $2.6 Million	105,238 Added 168.28%	167,775 $3.02 Million
Q4 2019 Feb 12, 2020	BUY	$19.93 - $29.13 $242,388 - $354,279	12,162 Added 24.14%	62,537 $1.48 Million
Q3 2019 Nov 12, 2019	BUY	$25.47 - $33.37 $493,837 - $647,010	19,389 Added 62.57%	50,375 $1.39 Million
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $436,786 - $566,685	-14,579 Reduced 32.0%	30,986 $1.03 Million
Q1 2019 May 14, 2019	SELL	$32.77 - $41.99 $570,001 - $730,374	-17,394 Reduced 27.63%	45,565 $1.6 Million
Q4 2018 Feb 13, 2019	SELL	$30.84 - $49.51 $225,656 - $362,264	-7,317 Reduced 10.41%	62,959 $2.09 Million
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $457,103 - $605,367	-10,705 Reduced 13.22%	70,276 $3.54 Million
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $124,229 - $168,597	-2,817 Reduced 3.36%	80,981 $4.85 Million
Q1 2018 May 15, 2018	BUY	$37.15 - $46.9 $830,265 - $1.05 Million	22,349 Added 36.37%	83,798 $3.84 Million
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $410,228 - $480,102	-11,270 Reduced 15.5%	61,449 $2.45 Million
Q3 2017 Nov 14, 2017	BUY	$36.75 - $49.65 $582,377 - $786,803	15,847 Added 27.86%	72,719 $2.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	56,872	56,872 $2.45 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account